ijms-logo

Journal Browser

Journal Browser

MicroRNAs in Physiology and Pathophysiology

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 25 December 2026 | Viewed by 2717

Special Issue Editor


E-Mail Website
Guest Editor
Department of Biochemistry and Molecular Biology, Medical University of Lublin, Chodźki 1, 20-093 Lublin, Poland
Interests: miRNA; biomarker; biochemistry, molecular biology

Special Issue Information

Dear Colleagues,

For more than twenty years, views on the biological roles of non-coding RNAs (ncRNAs) have been radically changing.

MicroRNAs (miRNAs) are well-known members of the ncRNA family that includes miRNAs, snRNAs, snoRNAs, scaRNAs, Y-RNAs, and piwiRNAs. MiRNAs are small, single-stranded RNAs about 22 nucleotides in length that are transcribed from our genome without the capacity to encode proteins. These ncRNAs are critical regulators of gene expression that affect a wide range of physiological processes necessary to maintain cellular homeostasis. On the other hand, the aberrant expression of miRNAs leads to various pathological conditions, particularly neoplastic disease. Binding of miRNAs to tumor suppressor and oncogene mRNAs is associated with cancer initiation, promotion, progression, and metastasis. Since the discovery of circulating miRNAs, the significance of these molecular players has increased, particularly as potential non-invasive biomarkers of different diseases. Importantly, it is known that miRNAs are promising markers also for prediction, disease monitoring, and therapy response in various human disease states. Currently, one of the main goals of miRNA research is to translate this theoretical knowledge into clinical practice.

This Special Issue is focused on recent advances in the involvement of miRNAs in physiological and pathological processes leading to different diseases. Discoveries of new molecular targets of miRNAs, miRNA-based diagnostic methods, and therapies are of special interest. Original research articles and reviews are welcome. We look forward to receiving your contributions.

Dr. Małgorzata Guz
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • miRNA
  • cell physiology
  • metabolism
  • cancer
  • biomarkers
  • disease
  • molecular mechanisms
  • diagnosis
  • therapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 1006 KB  
Article
Diagnostic Significance of Selected Plasma MicroRNAs in Myelodysplastic Syndromes
by Svilena Atanasova, Trifon Chervenkov, Maria Teneva, Stela Dimitrova and Ilina Micheva
Int. J. Mol. Sci. 2026, 27(5), 2250; https://doi.org/10.3390/ijms27052250 - 27 Feb 2026
Viewed by 321
Abstract
Myelodysplastic syndromes (MDSs) are clonal hematopoietic disorders characterized by ineffective hematopoiesis and their diagnosis remains challenging, requiring integration of clinical, morphological, and genetic data. MicroRNAs (miRNAs) have emerged as potential biomarkers in MDS, offering insights into disease mechanisms and patient stratification. This study [...] Read more.
Myelodysplastic syndromes (MDSs) are clonal hematopoietic disorders characterized by ineffective hematopoiesis and their diagnosis remains challenging, requiring integration of clinical, morphological, and genetic data. MicroRNAs (miRNAs) have emerged as potential biomarkers in MDS, offering insights into disease mechanisms and patient stratification. This study aimed to evaluate the diagnostic and prognostic significance of five plasma microRNAs (miR-22-3p, miR-144-3p, miR-16-5p, let-7a-5p, and miR-451a) in 40 patients with MDS, diagnosed according to WHO 2016 criteria and stratified by R-IPSS, and ten healthy controls. Plasma miRNA levels were measured by RT-qPCR. Expression profiles were compared between patients and controls, and further assessed in relation to disease subtypes, risk categories, and clinicopathological features. Expression analysis showed that miR-144-3p, miR-16-5p, let-7a-5p, and miR-451a were significantly lower in MDS patients compared to controls. MiR-451a demonstrated the highest diagnostic predictive value (p = 0.0022), followed by miR-16-5p (p = 0.0055), miR-144-3p (p = 0.0074), and let-7a-5p (p = 0.0092). Let-7a-5p was higher in MDS with excess blasts and both let-7a-5p and miR-451a were lower in the low-risk R-IPSS group. Strong correlations between miR-16-5p, miR-144-3p, and miR-451a were observed, probably reflecting their function in erythropoiesis. None of the investigated microRNAs showed independent prognostic significance for overall survival. In conclusion, circulating microRNAs, particularly miR-451a and let-7a-5p, show promise as supportive biomarkers that may complement existing diagnostic and risk assessment tools in MDS. Further studies are needed to validate their clinical applicability. Full article
(This article belongs to the Special Issue MicroRNAs in Physiology and Pathophysiology)
Show Figures

Figure 1

19 pages, 1651 KB  
Article
Dynamic microRNA Signatures as Biomarkers for Cardiac Ischemia and Remodeling
by Macarena Rodríguez-Serrano, Elena Martín-García, Patricia Alonso-Andrés, Elisa Conde-Moreno, Héctor Pian, Javier del Moral-Salmoral, Nunzio Alcharani, Miriam Menacho-Román, Lorena Crespo-Toro, Miren Edurne Ramos-Muñoz, Carlos Zaragoza, Luis Miguel Rincón, María G. Barderas and María Laura García-Bermejo
Int. J. Mol. Sci. 2026, 27(3), 1488; https://doi.org/10.3390/ijms27031488 - 3 Feb 2026
Cited by 1 | Viewed by 623
Abstract
Myocardial infarction (MI) triggers complex pathological processes, including inflammation, hypoxia, and fibrotic remodeling. MicroRNAs (miRNAs) have emerged as promising biomarkers for cardiovascular injury; however, their expression dynamics along processes remain underexplored. We used an in vivo rat model of permanent coronary occlusion to [...] Read more.
Myocardial infarction (MI) triggers complex pathological processes, including inflammation, hypoxia, and fibrotic remodeling. MicroRNAs (miRNAs) have emerged as promising biomarkers for cardiovascular injury; however, their expression dynamics along processes remain underexplored. We used an in vivo rat model of permanent coronary occlusion to study the molecular alterations associated with MI and its resolution in a temporal mode, including five experimental groups with five animals in each: sham, PO 24 h, PO 72 h, PO 7 d, PO 1 month. Histological analysis, serum biomarkers, and miRNA/gene expression profiles were analyzed in a time-dependent manner post-occlusion. Subsequent analysis revealed early depletion of selected circulating miRNAs (PO 24 h). Transient upregulation in cardiac tissue miRNAs, inflammatory and fibrotic gene expression (Fibronectin, Collagen, Vimentin, E-Cadherin) were observed at PO 72 h. These molecular alterations correlated with histological evidence of myocardial injury and repair. Taken together, our findings delineate the molecular timeline of MI progression and resolution and identify candidate miRNAs as sensitive and time-dependent indicators of myocardial stress, including miR-107, miR-122-5p and miR-221-3p. This integrative approach supports the use of miRNA signatures for noninvasive monitoring of cardiac injury and resolution and unveils potential therapeutic targets to reduce pathological remodeling. Full article
(This article belongs to the Special Issue MicroRNAs in Physiology and Pathophysiology)
Show Figures

Figure 1

29 pages, 5437 KB  
Article
MicroRNAs Let-7b-5p and miR-24-3p as Potential Therapeutic Agents Targeting Pancreatic Cancer Stem Cells
by Maricela Medrano-Silva, Eric Genaro Salmerón-Bárcenas, Elena Arechaga-Ocampo, Nicolas Villegas-Sepúlveda, Leopoldo Santos-Argumedo, Sonia Mayra Pérez-Tapia, Mayte Lizeth Padilla-Cristerna, Georgina Hernández-Montes, Gabriela Hernández-Galicia, Ana Beatriz Sánchez-Argáez, Paola Briseño-Díaz, Carmen Sánchez-Torres, Arturo Aguilar-Rojas, Andrea Martínez-Zayas, Miguel Vargas and Rosaura Hernández-Rivas
Int. J. Mol. Sci. 2025, 26(22), 11066; https://doi.org/10.3390/ijms262211066 - 15 Nov 2025
Viewed by 1334
Abstract
Pancreatic cancer poses a major clinical challenge due to its aggressiveness, frequent recurrence, and limited response to current chemotherapeutic approaches. Cancer stem cells (CSCs), particularly pancreatic CSCs (PCSCs), are key drivers of tumor initiation, therapeutic resistance, and disease relapse. MicroRNAs (miRNAs) have emerged [...] Read more.
Pancreatic cancer poses a major clinical challenge due to its aggressiveness, frequent recurrence, and limited response to current chemotherapeutic approaches. Cancer stem cells (CSCs), particularly pancreatic CSCs (PCSCs), are key drivers of tumor initiation, therapeutic resistance, and disease relapse. MicroRNAs (miRNAs) have emerged as critical regulators of CSC biology and influence self-renewal, pluripotency, and drug resistance through key signaling pathways. To identify PCSC-specific miRNAs, we enriched these cells using the pancreosphere culture method and isolated PCSC+ and PCSC− populations using FACS based on their expression of CD44, CD24, and CD133 surface markers. MicroRNA microarray analysis revealed 31 differentially expressed miRNAs (DEmiRNAs), of which 10 downregulated miRNAs were involved in pathways regulating pluripotency, including the Wnt/β-catenin, TGF-β, MAPK, and PI3K/AKT pathways. Then, 2 of these 10 DEmiRNAs, let-7b-5p and miR-24-3p, were selected for experimental validation. Their overexpression in PCSC+ cells inhibited these pathways, downregulated pluripotency factors, and induced differentiation into endocrine and exocrine phenotypes, as confirmed by RT-qPCR, Western blot, and RNA-seq. Functionally, each miRNA reduced sphere formation, increased gemcitabine sensitivity, and suppressed tumorigenicity in vivo, highlighting their potential as therapeutic candidates. Restoring tumor-suppressive miRNA expression may offer a novel strategy to overcome chemoresistance and improve outcomes in pancreatic cancer. Full article
(This article belongs to the Special Issue MicroRNAs in Physiology and Pathophysiology)
Show Figures

Figure 1

Back to TopTop